Gritstone bio, Inc is a biotechnology business based in the US. Gritstone bio shares (GRTS) are listed on the NASDAQ and all prices are listed in US Dollars. Gritstone bio employs 172 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Gritstone bio
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – GRTS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Gritstone bio stock price (NASDAQ: GRTS)Use our graph to track the performance of GRTS stocks over time.
Gritstone bio shares at a glance
|Latest market close||$9.20|
|52-week range||$2.54 - $28.52|
|50-day moving average||$8.89|
|200-day moving average||$11.26|
|Wall St. target price||$32.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.21|
Buy Gritstone bio shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Gritstone bio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Gritstone bio price performance over time
|1 week (2021-07-20)||N/A|
|1 month (2021-07-01)||1.77%|
|3 months (2021-04-30)||1.66%|
|6 months (2021-01-27)||N/A|
|1 year (2020-07-27)||N/A|
|2 years (2019-07-27)||N/A|
|3 years (2018-07-27)||N/A|
|5 years (2016-07-27)||N/A|
Gritstone bio financials
|Revenue TTM||$42.5 million|
|Gross profit TTM||$-84,606,000|
|Return on assets TTM||-21.79%|
|Return on equity TTM||-45.23%|
|Market capitalisation||$365.3 million|
TTM: trailing 12 months
Shorting Gritstone bio shares
There are currently 5.1 million Gritstone bio shares held short by investors – that's known as Gritstone bio's "short interest". This figure is 5.6% up from 4.8 million last month.
There are a few different ways that this level of interest in shorting Gritstone bio shares can be evaluated.
Gritstone bio's "short interest ratio" (SIR)
Gritstone bio's "short interest ratio" (SIR) is the quantity of Gritstone bio shares currently shorted divided by the average quantity of Gritstone bio shares traded daily (recently around 501535.27093596). Gritstone bio's SIR currently stands at 10.15. In other words for every 100,000 Gritstone bio shares traded daily on the market, roughly 10150 shares are currently held short.
However Gritstone bio's short interest can also be evaluated against the total number of Gritstone bio shares, or, against the total number of tradable Gritstone bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Gritstone bio's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Gritstone bio shares in existence, roughly 100 shares are currently held short) or 0.1454% of the tradable shares (for every 100,000 tradable Gritstone bio shares, roughly 145 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Gritstone bio.
Find out more about how you can short Gritstone bio stock.
Gritstone bio share dividends
We're not expecting Gritstone bio to pay a dividend over the next 12 months.
Gritstone bio share price volatility
Over the last 12 months, Gritstone bio's shares have ranged in value from as little as $2.535 up to $28.5215. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Gritstone bio's is 0.1404. This would suggest that Gritstone bio's shares are less volatile than average (for this exchange).
Gritstone bio overview
Gritstone bio, Inc. , a clinical-stage biotechnology company, engages in developing tumor-specific cancer immunotherapies to fight various cancer types and infectious diseases. Its lead product candidate is GRANITE, which is in Phase I/II clinical trial for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors, including metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and other mutation-positive tumors. Gritstone Oncology, Inc. has a strategic collaboration with bluebird bio, Inc. The company was formerly known as Gritstone Oncology, Inc.
Stocks similar to Gritstone bio
Gritstone bio in the news
Onxeo Announces the Appointment of Dr. Shefali Agarwal as the Company’s Chairwoman of the Board
If You Had Bought Gritstone bio (NASDAQ:GRTS) Stock A Year Ago, You Could Pocket A 108% Gain Today
Did You Miss Gritstone bio's (NASDAQ:GRTS) Impressive 102% Share Price Gain?
Frequently asked questionsWhat percentage of Gritstone bio is owned by insiders or institutions?
Currently 3.79% of Gritstone bio shares are held by insiders and 69.766% by institutions. How many people work for Gritstone bio?
Latest data suggests 172 work at Gritstone bio. When does the fiscal year end for Gritstone bio?
Gritstone bio's fiscal year ends in December. Where is Gritstone bio based?
Gritstone bio's address is: 5959 Horton Street, EmeryVille, CA, United States, 94608 What is Gritstone bio's ISIN number?
Gritstone bio's international securities identification number is: US39868T1051 What is Gritstone bio's CUSIP number?
Gritstone bio's Committee on Uniform Securities Identification Procedures number is: 39868T105
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert